{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1581135651662578944.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@language":"ja","@value":"江藤精二"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1571135651662578944","@type":"Article","productIdentifier":[{"@type":"NAID","@value":"80005293766"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/1991160168"}],"notation":[{"@value":"Pseudo-Bartter 症候群を呈した患者尿からのフロセミド検出"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CIA","@value":"80005293766_Hhh1IkXw5dRLGDiokGEFWI2q9BP"}]}